文 献oral absorption. AAPS J 2009; 11: 277-85.10）Ichijo K, Oda R, Ishihara M, Okada R, Moteki Y, Funai Y, et al. Osmolality of orally administered solutions influences luminal water volume and drug absorption in intestine. J Pharm Sci 2017; 106: 2889-94.11）Funai Y, Shirasaka Y, Ishihara M, Takemura M, Ichijo K, Kishimoto H, et al. Effect of osmolality on the pharmacokinetic interaction between apple juice and atenolol in rats. Drug Metab Dispos 2019; 47: 386-91.12）Suzuki S, Shirasaka Y, Okada R, Eguchi A, Kishimoto H, Langguth P, et al. Quantitative analysis of the effect of controlled-release formulation on nonlinear gastrointestinal absorption of P-glycoprotein substrate talinolol using physiologically based pharmacokinetic absorption model. J Drug Deliv Sci Technol 2019; In press.13）Tubic M, Wagner D, Spahn-Langguth H, Weiler C, Wanitschke R, Böcher WO, et al. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans. Eur J Pharm Sci 2006; 29: 231-9.14）Bolger MB, Lukacova V, Woltosz WS. Simulations of the nonlinear dose dependence for substrates of influx and efflux transporters in the human intestine. AAPS J 2009; 11: 353-63.15）Schiller C, Fröhlich CP, Giessmann T, Siegmund W, Mönnikes H, Hosten N, et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 2005; 22: 971-9.1001）Shirasaka Y, Mori T, Murata Y, Nakanishi T, Tamai I. Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1. Pharm Res 2014; 31: 2035-43.2）Shirasaka Y, Sakane T, Yamashita S. Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane. J Pharm Sci 2008; 97: 553-65.3）Sutton SC. Role of physiological intestinal water in 4）Crounse RG. Human pharmacology of griseofulvin: the effect of fat intake on gastrointestinal absorption. J Invest Dermatol 1961; 37: 529-33.5）Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991; 337: 268-9.6）Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002; 71: 11-20.7）Jeon H, Jang IJ, Lee S, Ohashi K, Kotegawa T, Ieiri I, et al. Apple juice greatly reduces systemic exposure to atenolol. Br J Clin Pharmacol 2013; 75: 172-9.8）Misaka S, Yatabe J, Muller F, Takano K, Kawabe K, Glaeser H, et al. Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther 2014; 95: 432-8.9）Shirasaka Y, Shichiri M, Mori T, Nakanishi T, Tamai I. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions. J Pharm Sci 2013; 102: 280–8.
元のページ ../index.html#114